Age, Biography and Wiki
Beth Overmoyer was born on 1960, is an American physician and oncologist. Discover Beth Overmoyer's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 64 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
64 years old |
Zodiac Sign |
|
Born |
1960 |
Birthday |
1960 |
Birthplace |
N/A |
Nationality |
|
We recommend you to check the complete list of Famous People born on 1960.
She is a member of famous physician with the age 64 years old group.
Beth Overmoyer Height, Weight & Measurements
At 64 years old, Beth Overmoyer height not available right now. We will update Beth Overmoyer's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.
Family |
Parents |
Not Available |
Husband |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Beth Overmoyer Net Worth
Her net worth has been growing significantly in 2023-2024. So, how much is Beth Overmoyer worth at the age of 64 years old? Beth Overmoyer’s income source is mostly from being a successful physician. She is from . We have estimated Beth Overmoyer's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
physician |
Beth Overmoyer Social Network
Instagram |
|
Linkedin |
|
Twitter |
|
Facebook |
|
Wikipedia |
|
Imdb |
|
Timeline
Beth Ann Overmoyer (born 1960) is an American physician and oncologist.
She is Director of the Inflammatory Breast Cancer Program at the Dana–Farber Cancer Institute.
Overmoyer was an undergraduate student in biology and graduated magna cum laude.
She was a medical student at the Case Western Reserve University, before moving to the University of Pennsylvania for her internship and medical residence.
She became interested in oncology in the late eighties, when she started researching breast cancer at the Hospital of the University of Pennsylvania.
Overmoyer was appointed to the Cleveland Clinic, where she was made the hospital director of breast cancer.
She dedicated her career to breast cancer prevention and the treatment of early-stage disease.
Alongside leading several clinical trials, early in her career she was involved with a review into the United States Department of Defense funding for breast cancer research.
She was one of the first to demonstrate high dose chemotherapy – autologous stem-cell transplantation to treat metastatic carcinoma.
In 2007, Overmoyer moved to the Dana–Farber Cancer Institute, where she established the Inflammatory Breast Cancer Program in 2009.
Inflammatory breast cancer is a rare, fast-growing disease, which causes the lymph vessels within breast skins to become clogged with tumor cells.
Overmoyer established the Inflammatory Breast Cancer Registry, a repository of information and tumor samples to aid with the understanding and diagnosis of the disease.
She showed that Ruxolitinib was capable of suppressing the inflammatory breast cancer pathway in patients with triple-negative breast cancer.
Overmoyer studied the clinical benefits of Enobosarm (an androgen receptor modulator) in patients with androgen receptor positive and estrogen receptor positive breast cancer.
She found that Enobosarm was well tolerated, safe and showed clinical benefit.
She is also an assistant professor of medicine and Harvard Medical School.